Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis

Natriuretic Peptide-Guided Therapy in Chronic Heart Failure: A Meta-Analysis of 2,686 Patients in 12 Randomized Trials

(2013) Gianluigi Savarese et al.   PLoS One

Use of biomarkers to guide outpatient therapy of heart failure

(2012) Benedetta DeBeradinis et al.   CURRENT OPINION IN CARDIOLOGY

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

(2012) L. Gullestad et al.   EUROPEAN HEART JOURNAL

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

(2012) et al.   EUROPEAN HEART JOURNAL

Cost-effectiveness analysis of serial measurement of circulating natriuretic peptide concentration in chronic heart failure

(2012) Philippe Laramée et al.   HEART

Determinants and Consequences of Renal Function Variations With Aldosterone Blocker Therapy in Heart Failure Patients After Myocardial Infarction

(2011) Patrick Rossignol et al.   CIRCULATION

Clinical outcome of renal tubular damage in chronic heart failure†

(2011) Kevin Damman et al.   EUROPEAN HEART JOURNAL

Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome

(2011) Patric Karlström et al.   EUROPEAN JOURNAL OF HEART FAILURE

The STARBRITE Trial: A Randomized, Pilot Study of B-Type Natriuretic Peptide–Guided Therapy in Patients With Advanced Heart Failure

(2011) Monica R. Shah et al.   JOURNAL OF CARDIAC FAILURE

Use of Amino-Terminal Pro–B-Type Natriuretic Peptide to Guide Outpatient Therapy of Patients With Chronic Left Ventricular Systolic Dysfunction

(2011) James L. Januzzi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

B-Type Natriuretic Peptide–Guided Heart Failure Therapy

(2010) Pramote Porapakkham   ARCHIVES OF INTERNAL MEDICINE

Lifetime Costs of Medical Care After Heart Failure Diagnosis

(2010) Shannon M. Dunlay et al.  

Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure - SIGNAL-HF (Swedish Intervention study - Guidelines and NT-proBNP AnaLysis in Heart Failure)

(2010) Hans Persson et al.   EUROPEAN JOURNAL OF HEART FAILURE

Management of Chronic Heart Failure Guided by Individual N-Terminal Pro–B-Type Natriuretic Peptide Targets

(2010) Luc W.M. Eurlings et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Serum Soluble ST2

(2010) Robin A.P. Weir et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Utilidad de los valores del péptido natriurético cerebral frente al control clínico habitual para la monitorización del tratamiento en pacientes con insuficiencia cardiaca

(2010) Manuel Anguita et al.   MEDICINA CLINICA

Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials

(2009) G. Michael Felker et al.   AMERICAN HEART JOURNAL

2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults

(2009) et al.   CIRCULATION

BNP-Guided vs Symptom-Guided Heart Failure Therapy

(2009) Matthias Pfisterer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

N-Terminal Pro–B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure

(2009) John G. Lainchbury et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)

(2008) Serge Masson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Biomarkers in Heart Failure

(2008) Eugene Braunwald   NEW ENGLAND JOURNAL OF MEDICINE